Drug Profile
Research programme: genetically modified NK cells - St. Jude Children's Research Hospital
Alternative Names: Anti-cancer therapy - St Jude Children's Research HospitalLatest Information Update: 20 Feb 2008
Price :
$50
*
At a glance
- Originator St. Jude Childrens Research Hospital
- Class
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Precursor cell lymphoblastic leukaemia-lymphoma
Most Recent Events
- 31 May 2005 Investigation in Acute lymphoblastic leukaemia in USA (unspecified route)